139 related articles for article (PubMed ID: 17452140)
1. Letter of comment on "Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial" (Am Heart J 2006;152:887.e9-14).
Vydt T; Agostoni P
Am Heart J; 2007 May; 153(5):e25; author reply e27. PubMed ID: 17452140
[No Abstract] [Full Text] [Related]
2. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
[TBL] [Abstract][Full Text] [Related]
3. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
4. Letter by Venetucci et al regarding article "Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial".
Venetucci L; Fath-ordoubadi F; Fraser D
Circ Cardiovasc Interv; 2009 Dec; 2(6):e5; author reply e6. PubMed ID: 20031762
[No Abstract] [Full Text] [Related]
5. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction.
Pasceri V; Pristipino C; Pelliccia F; Granatelli A; Speciale G; Roncella A; Pironi B; Capasso M; Richichi G
Am J Cardiol; 2005 Jun; 95(11):1358-61. PubMed ID: 15904643
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.
Parikh KH; Chag MC; Shah KJ; Shah UG; Baxi HA; Chandarana AH; Naik AM; Shah JN; Shah HD; Goyal RK
Can J Physiol Pharmacol; 2007; 85(3-4):476-82. PubMed ID: 17612657
[TBL] [Abstract][Full Text] [Related]
7. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon.
Barcin C; Denktas AE; Lennon RJ; Hammes L; Higano ST; Holmes DR; Garratt KN; Lerman A
Catheter Cardiovasc Interv; 2004 Apr; 61(4):484-91. PubMed ID: 15065143
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Armstrong PW; Adams PX; Al-Khalidi HR; Hamm C; Holmes D; O'Neill W; Todaro TG; Vahanian A; Van de Werf F; Granger CB;
Am Heart J; 2005 Mar; 149(3):402-7. PubMed ID: 15864228
[No Abstract] [Full Text] [Related]
9. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
[TBL] [Abstract][Full Text] [Related]
10. Comparison of combination therapy of adenosine and nitroprusside with adenosine[correction for adensosine] alone in the treatment of angiographic no-reflow phenomenon: does 1 plus 1 equal 11?
Bailey SR
Catheter Cardiovasc Interv; 2004 Apr; 61(4):492-3. PubMed ID: 15065144
[No Abstract] [Full Text] [Related]
11. [Study of no-reflow phenomenon after reperfusion for acute myocardial infarction].
Yang YJ; Zhao JL
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2169-70. PubMed ID: 16321176
[No Abstract] [Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
13. The use of intracoronary sodium nitroprusside to treat no-reflow after primary percutaneous coronary intervention in acute myocardial infarction.
Tesic MB; Stankovic G; Vukcevic V; Ostojic MC
Herz; 2010 Mar; 35(2):114-8. PubMed ID: 20376646
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of a slowly growing pseudoaneurysm and restenosis in coronary artery following primary percutaneous coronary intervention in a patient with acute myocardial infarction.
Açikel M; Aribaş A; Senocak H
Anadolu Kardiyol Derg; 2009 Apr; 9(2):141-2. PubMed ID: 19357058
[No Abstract] [Full Text] [Related]
15. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
[TBL] [Abstract][Full Text] [Related]
16. "High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation: A randomized controlled trial evaluating the relationship to endothelial function and inflammation." Am Heart J 2009;158:734-41.
Meyer P; Gayda M; Normandin E; Guiraud T; Juneau M; Nigam A
Am Heart J; 2010 Mar; 159(3):e21. PubMed ID: 20211291
[No Abstract] [Full Text] [Related]
17. Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction.
Shinozaki N; Ichinose H; Yahikozawa K; Shimada H; Hoshino K
Int Heart J; 2007 Jul; 48(4):423-33. PubMed ID: 17827814
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes.
Srinivasan M; Rihal C; Holmes DR; Prasad A
Circulation; 2009 Mar; 119(9):1311-9. PubMed ID: 19273732
[TBL] [Abstract][Full Text] [Related]
19. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
[TBL] [Abstract][Full Text] [Related]
20. No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction.
Abbate A; Kontos MC; Biondi-Zoccai GG
Eur Heart J; 2008 Aug; 29(15):1795-7. PubMed ID: 18617478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
